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Conclusion: Prostaglandin E2, the predominant eicosanoid pro- 
duced by OA chondrocytes, exerts catabolic effects within carti- 
lage. These deleterious effects require signaling via the EP4 re- 
ceptor, which should be considered as a potential target for dis- 
ease modifying agents in OA. 
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Study Aims: We report here the existence of a novel posttrans- 
lational processing pathway for lubricin in synovial lining cells, 
and show opposed regulation of glycosylation and aggregation 
by growth factors (TGFb) and cytokines (IL6 and LIF) involved in 
post-injury joint disease. 
Histological and cellular changes to the synovial lining are fre- 
quently reported in both animal models and human OA. While 
synovial histopathology is well described, very little is known 
about the pathway that links cellular changes in this tissue to 
degradation and remodeling of joint tissues which is a hallmark 
of late stage OA. A major function of the synovial lining cell is the 
secretion of macromolecular components of the joint fluid, such 
as hyaluronan (HA) and lubricin (LB). We report here novel obser- 
vations on the effect of OA-relevant cytokines on the biosynthesis 
and assembly of lubricin multimers. 
Methods: Synovial membranes from bovine metacarpalpha- 
langeal joints, were digested in collagenaseP (0.1%). Tissue rem- 
nants were removed with a cell sieve, cells washed and plated 
at lx106 cells/100 mm dish in DMEM/20% FCS. Following 1 
passage, confluent cells were supplemented for 48 h with and 
without TGFb alone and in combination with LIE Conditioned 
media fractionated by MonoQ ion exchange and separated iso- 
forms of lubricin were further analyzed by Agarose GE and 
Westerns with anti-peptide antibodies (JSCIQQ and JSCLPN) to 
the N-terminal (19-1QQVSSQ DLSC) and the C-terminal (1345- 
LPNVVTSAISLPNIRKPD) sequences. 
Results: AGE analyses of native and reduced/alkylated prepa- 
rations showed that control cultures secreted lubricin as both, 
monomers and disulfide-bonded aggregates. TGF-b caused a 
marked increase in the production of lubricin, predominantly as 
a monomeric low-charge glycoform much of which lacked the N- 
terminal epitope IQQ. When cultures were exposed to LIF, a 'shift' 
back to the 'control' culture condition occurred with synthesis of 
the low charge glycoform reduced, and less N-terminal epitope 
loss. To examine the effect of LIF on lubricin organization in the 
cell-associated matrix, cytokine-treated cell layers were fixed in 
Histochoice and examined by confocal IHC. The control cultures 
showed intense staining of the ECM domain closely associated 
with the cells. Treatment with TGF-b resulted in a marked re- 
organization of LB staining with very few intense ECM-positive 
cells remaining, most cells showed only a diffuse staining which 
appeared to be intracellular. When LIF was added at the same 
time as TGF-b the LB-positive cells now displayed the intense 
cell-associated ECM typical of control untreated cells, support- 
ing the idea that LIF can restore the 'mature secretory' synovial 
phenotype in a post-injury joint. An investigation of the signaling 
pathway for this LIF-mediated effect suggests that it involves an 
intracellular response of SOCS1. 
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Aim of Study: Heme oxygenase-1 (HO-1) is induced as an adap- 
tive mechanism against tissue injury. We have recently demon- 
strated that basal expression of HO-1 in human osteoarthritis 
(OA) chondrocytes is negatively regulated by inflammatory cy- 
tokines. In this study we have investigated whether the modula- 
tion of the HO-1 pathway could be able to attenuate the effects of 
OA. 
Methods: We have treated human OA chondrocytes with a HO-1 
inducer, cobalt protoporphyrin IX (CoPP), or with a CO donor, tri- 
carbonyldichlororuthenium (11) (TCCT) and assessed different OA 
markers in chondrocytes timulated with IL-11~. Cartilage speci- 
mens were obtained from 17 patients with diagnosis of advanced 
OA undergoing total knee joint replacement. Chondrocytes were 
used in primary culture. Cells were treated with 100 U/ml I L-11~, 
and 10 I~M CoPP or 100 I~M TCCT for24 h. 
Results: CoPP, and interestingly TCCT, significantly increased 
HO-lexpression in non-treated and IL-11~ stimulated chondro- 
cytes versus basal chondrocytes. Both drugs decreased the pro- 
duction of different inflammatory mediators (IL-6, TNF~, NO, 
PGE2), and IL-10. We have evaluated some markers of cell cy- 
cle arrest, apoptosis induction, and phenotype changes. TCCT 
was able to down-regulate p21 and Bax protein expression. Treat- 
ment with this agent resulted in a lower number of cells with DNA 
fragmentation and absence of droplets in cytoplasm in compari- 
son with control cells stimulated with IL-11~. In studies of cartilage 
degradation, CoPP was able to reduce proteoglycan degradation 
in OA explants, whereas TCCT down-regulated IGFBP-3 expres- 
sion in chondrocytes timulated with IL-11~, which may be related 
to a lower catabolism of cartilage matrix molecules. 
Conclusions: These results suggest a correlation between HO- 
land the reduction of tissue damage in human OA chondrocytes 
and support a protective role for HO-1 in OA. 
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Aim: IGF-I and OP-1 are key anabolic factors in adult articular 
cartilage. Recent studies have shown that bFGF is released from 
the adult cartilage matrix upon cartilage injury and mechanical 
stimulation. The aim of this study was to determine the effects 
of bFGF on chondrocyte proliferation and matrix synthesis in the 
presence of IGF-I and OP-1. 
Methods: Human articular chondrocytes were isolated from nor- 
mal ankle cartilage obtained from 9 tissue donors with ages of 
47-73 years. Cells were cultured in alginate beads or as carti- 
lage explants in serum-free media supplemented with mini-ITS 
with or without IGF-1 (100ng/ml), OP-1 (100ng/ml) or bFGF (0- 
100ng/ml). The cells and their pericellular matrix were visualized 
with the particle exclusion assay. Cell survival (LIVE-DEAD Cell 
Assay), proliferation (DNA levels), proteoglycan synthesis (sulfate 
incorporation), and total proteoglycan accumulation (DMB dye 
binding assay) were measured after 21 days of culture in algi- 
$146 Poster Presentat ions 
nate beads. Sulfate incorporation was measured over the final 4 
hours of culture at day 10 or 21 day for explants. 
Results: bFGF added to any of the culture conditions did not 
alter cell survival, bFGF in alginate cultures resulted in the for- 
mation of cell clusters that lacked a visible pericellular matrix and 
the addition of bFGF to IGF+OP-1 treated cultures was seen to 
inhibit the ability of the latter growth factors to stimulate pericel- 
lular matrix formation. Chondrocyte proliferation was stimulated 
at doses above lng/ml of bFGF with a maximal 2-fold increase 
at100 ng/ml. However, the 1 ng/ml dose of bFGF was sufficient o 
stimulate proliferation when combined with IGF-I or with IGF+OP- 
1, the latter resulting in the greatest stimulation of proliferation 
which was over 3.5-fold of control. The increase in cell num- 
bers correlated with a decrease in total proteoglycan (PG) lev- 
els accumulated per cell (DMB/DNA) which was 40% of control 
at 100ng/ml bFGE Although IGF-I, OP-1, or IGF-I+OP-1 signif- 
icantly increased proteoglycan levels above controls, the addi- 
tion of bFGF to these cultures resulted in significant inhibition 
of proteoglycan synthesis below levels of untreated control (45% 
of control with IGF-I+bFGF vs 128% of control with IGF-I alone; 
55% of control with OP-I+bFGF vs 186% of control with OP-1 
alone and 40% of control for bFGF+IGF-I+OP-1 vs 165% of con- 
trol with IGF-I+OP-1). Likewise, sulfate incorporation (as a mea- 
sure of new PG synthesis) in response to IGF-I and OP-1 alone 
or together was completely inhibited by 50ng/ml bFGE Similar 
effects on proteoglycan synthesis were obtained in cartilage ex- 
plants where 50ng/ml bFGF totally inhibited the ability of IGF-I or 
OP-1, alone or together, to stimulate sulfate incorporation. 
Conclusion: In adult human articular cartilage, bFGF stimulates 
proliferation at doses above lng/ml and significantly inhibits the 
anabolic activity of IGF-I and OP-1. The results suggest that ex- 
cessive release of bFGF from the cartilage matrix during injury, 
with loading, or in arthritis could contribute to reduced anabolic 
activity in cartilage. 
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Purpose: Expression of PGE2 depends upon simultaneous ex- 
pression of a cyclooxygenase (COX-l, or COX-2) and an asso- 
ciated terminal PGE synthase (PGES), in order to convert the 
COX product PGH2 into PGE2. We examined the expression 
and subcellular localization of COX-l, COX-2, microsomal PGES 
(mPGES, inducible, presumed to associate with COX-2) and cy- 
tosolic PGES (cPGES, presumed to associate with COX-l), in 
chondrocytes (C2812 cell line kindly provided by Mary Goldring) 
stimulated with IL-1. 
Methods: C2812 cells were stimulated (various times) with IL- 
1beta (10ng/ml). Lysates were analyzed for COX-l, COX-2, 
cPGES and mPGES protein and mRNA. Cells fractionated into 
nuclear and cytoplasmic components were analyzed for COXs 
and PGESs by western blot. Supernatants were analyzed for 
PGE2. 
Results: mRNA and protein for both COX-1 and cPGES were 
present in unstimulated C2812 chondrocytes; COX-1 and cPGES 
mRNA and protein levels did not change substantially with IL-1 
stimulation over a period of 24 h. In contrast, mRNA and pro- 
tein for both COX-2 and mPGES were not expressed in unstim- 
ulated C2812 cells, but were upregulated by IL-1. COX-2 protein 
was observed as early as 4 h after stimulation, reaching maxi- 
mal levels shortly thereafter, mPGES protein expression was ob- 
served somewhat later, with a peak at 24 h. Subcellular fraction- 
ation revealed that COX-1 was localized primarily to the nucleus 
(nuclear membrane), with unchanged distribution in response to 
IL-1. COX-2 and mPGES also were localized to the nucleus, but 
only after IL-1-induced expression. In contrast, cPGES was local- 
ized primarily to the cytosol, with little or no cPGES in the nuclear 
fraction of unstimulated cells. Upon IL-1 stimulation, the amount 
of cPGES at the nuclear membrane rapidly and transiently in- 
creased (maximum 236% of unstimulated at 30 min, return to 
baseline by 4 h), indicating early translocation of a portion of 
cPGES to the nucleus, and suggesting a possible COX-1/mPGES 
assemblage. Measurement of extracellular PGE2 in response to 
IL-1 revealed three phases: an early accumulation (peak 30 min; 
146% of unstimulated control) presumably related to assembly of 
the COX-1/cPGES system, a plateau phase (126% of control at 
2 h), and a late phase of production (1645% of control at 24 h), 
presumably related to a COX-2/mPGES system. 
Conclusion: Our data suggest that, in response to IL-1, PGE2 
production may occur through sequential generation and/or as- 
sembly of two sets of PGE2-producing systems: an early sys- 
tem composed of constitutively expressed COX-1/cPGES, requir- 
ing translocation of cPGES to the nuclear membrane where a 
PGE synthetic complex may be assembled, and a later, COX- 
2/mPGES system that depends on stimulated, nuclear mem- 
brane expression of both of these proteins. 
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Purpose: Cartilage degradation is a hallmark in osteoarthritis 
(OA) and loss of estrogen has been shown to be associated with 
increased prevalence of OA in postmenopausal women. It re- 
mains to be elucidated whether this potential chondroprotective 
effect of estrogen is mediated directly or indirectly on chondro- 
cytes. 
We investigated i) the effect of estrogen treatment or prevention 
on cartilage health in the rat OVX model and ii) the direct effects 
of estrogen on cartilage turnover in an cartilage explant model. 
Materials and methods: In vivo, forty 7-month old Sprague- 
Dawley rats were divided into four groups. One group was sub- 
jected to sham operation, whereas the others to OVX, followed by 
treatment with either vehicle alone, 17-b-estradiol [0.25mg/pellet 
s.c.] initiated instantly or 3 weeks after surgery and continued 
until termination after 9 weeks. Cartilage erosion was evaluated 
histologically by assessment of proteoglycan staining followed by 
microscopic measurement of eroded surface length in the articu- 
lar cartilage. Ex vivo, for articular cartilage explants culture, 144-2 
mg cartilage was isolated from bovine heifer stifle joints, and cul- 
tured in 96-well plates. Cartilage degradation was induced by on- 
costatin M (OSM) [10 ng/mL] and TNF-~ [20 ng/mL], in the pres- 
ence or absence of 17-1~-estradiol [0.1 nM - 1 I~M]. In both the 
in vivo and ex vivo settings, cartilage degradation was estimated 
by measuring the concentration of the C-telopeptide fragments 
of collagen type II (CTX-II) in serum and conditioned medium, 
respectively. 
Results: Ovariectomy induced a 66% increase in serum CTX- 
II levels compared with sham-operated animals (P<0.001), indi- 
cating an increase in cartilage degradation. In accordance with 
the accelerated collagen degradation, there was a 53% increase 
in the extent of cartilage erosion compared to sham-operated 
